Anacalpysis Therapeutics

Anacalypsis focuses on discovering therapies for neurodegenerative diseases, such as Parkinson’s disease, for which there are currently no disease-modifying treatments and diagnosis is typically late. The company develops gene therapies and biomarkers and designs compounds that modulate protein–protein interactions.